These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30697570)

  • 21. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.
    Sise ME; Hirsch JS; Canetta PA; Herlitz L; Mohan S
    AIDS; 2015 May; 29(8):941-6. PubMed ID: 25784440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).
    Oboho I; Abraham AG; Benning L; Anastos K; Sharma A; Young M; Burian P; Gandhi M; Cohen M; Szczech L
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):388-95. PubMed ID: 23254151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service.
    Turner D; Drak D; O'Connor CC; Templeton DJ; Gracey DM
    AIDS Res Ther; 2019 Dec; 16(1):40. PubMed ID: 31810490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of tenofovir and renal disease for the HIV-treating clinician.
    Venter WDF; Fabian J; Feldman C
    South Afr J HIV Med; 2018; 19(1):817. PubMed ID: 30167339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers.
    Mogalian E; Stamm LM; Osinusi A; Brainard DM; Shen G; Ling KHJ; Mathias A
    Clin Infect Dis; 2018 Aug; 67(6):934-940. PubMed ID: 29522076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief Report: Urine Emtricitabine and Tenofovir Concentrations Provide Markers of Recent Antiretroviral Drug Exposure Among HIV-Negative Men Who Have Sex With Men.
    Haaland RE; Martin A; Livermont T; Fountain J; Dinh C; Holder A; Lupo LD; Hall L; Conway-Washington C; Kelley CF
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):252-256. PubMed ID: 31335590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma tenofovir trough concentrations are associated with renal dysfunction in Japanese patients with HIV infection: a retrospective cohort study.
    Kunimoto Y; Ikeda H; Fujii S; Kitagawa M; Yamazaki K; Nakata H; Noda N; Ishida T; Miyamoto A
    J Pharm Health Care Sci; 2016; 2():22. PubMed ID: 27688900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients.
    Campbell LJ; Dew T; Salota R; Cheserem E; Hamzah L; Ibrahim F; Sarafidis PA; Moniz CF; Hendry BM; Poulton M; Sherwood RA; Post FA
    BMC Nephrol; 2012 Aug; 13():85. PubMed ID: 22883485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.
    Cao Y; Han Y; Xie J; Cui Q; Zhang L; Li Y; Li Y; Song X; Zhu T; Li T
    BMC Infect Dis; 2013 Jul; 13():301. PubMed ID: 23815472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study.
    Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella FJ; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak MG
    Am J Kidney Dis; 2016 Oct; 68(4):571-581. PubMed ID: 27287300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
    Patricio JA; Lopes PF; Medeiros T; Mendes GF; Silva AA; Esberard EB; Lugon JR; Almeida JR
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):64-9. PubMed ID: 26545084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?
    Schwarze-Zander C; Piduhn H; Boesecke C; Schlabe S; Stoffel-Wagner B; Wasmuth JC; Strassburg CP; Rockstroh JK
    HIV Med; 2020 Jul; 21(6):378-385. PubMed ID: 32065713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
    LaFleur J; Bress AP; Esker S; Knippenberg K; Crook J; Nyman H; Bedimo R; Tebas P; Rosenblatt L
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):325-330. PubMed ID: 29210830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
    Likanonsakul S; Suntisuklappon B; Nitiyanontakij R; Prasithsirikul W; Nakayama EE; Shioda T; Sangsajja C
    PLoS One; 2016; 11(1):e0147724. PubMed ID: 26807589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study.
    Mills A; Crofoot G; McDonald C; Shalit P; Flamm JA; Gathe J; Scribner A; Shamblaw D; Saag M; Cao H; Martin H; Das M; Thomas A; Liu HC; Yan M; Callebaut C; Custodio J; Cheng A; McCallister S
    J Acquir Immune Defic Syndr; 2015 Aug; 69(4):439-45. PubMed ID: 25867913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenofovir nephrotoxicity among Asians living with HIV: review of the literature.
    Nishijima T; Gatanaga H; Oka S
    Glob Health Med; 2019 Dec; 1(2):88-94. PubMed ID: 33330761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India.
    Kumarasamy N; Sundaram S; Poongulali S; Ezhilarasi C; Pradeep A; Chitra D
    J Virus Erad; 2018 Jan; 4(1):37-40. PubMed ID: 29568552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice.
    Bhattacharya D; Belperio PS; Shahoumian TA; Loomis TP; Goetz MB; Mole LA; Backus LI
    Clin Infect Dis; 2017 Jun; 64(12):1711-1720. PubMed ID: 28199525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patients.
    Cheng CY; Chang SY; Lin MH; Ku SY; Sun NL; Cheng SH
    J Infect Chemother; 2016 Nov; 22(11):744-747. PubMed ID: 27613487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide.
    Fong TL; Lee BT; Tien A; Chang M; Lim C; Ahn A; Bae HS
    J Viral Hepat; 2019 May; 26(5):561-567. PubMed ID: 30576085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.